About Binax
Binax is a Healthcare company based in Portland (United States) founded in 1986, and was acquired by Abbott in February 2005. POC products for infectious disease. Binax offers products and services including BinaxNOW COVID-19 Antigen Self Test and BinaxNOW COVID-19/Flu A&B Combo Self Test. Its focus areas include Life Sciences, Infectious Diseases, In Vitro Diagnostic Tests and Diversified. Its competitors include Inflammatix, Karius and Visby Medical; 3 of its 3 listed competitors have raised funding.
Company details
Binax is focused in the development, manufacture, and marketing of a wide range of diagnostic tests for infectious diseases. The company sells a range of lateral flow immunochromatographic assay based tests for Legionella pneumophila, Streptococcus pneumoniae, Strep A, Flu A, Flu B, Ragged stunt virus, NOW Malaria, Hepatitis B, and Filariasis tests. The company was acquired by Inverness Medical Innovations, Inc in Feb, 2005.
- Investors
- Acquired byAbbott
(Feb 2005)
Products & Services of Binax
Binax offers a comprehensive portfolio of products and services, including BinaxNOW COVID-19 Antigen Self Test and BinaxNOW COVID-19/Flu A&B Combo Self Test.
Rapid at-home test for detecting COVID-19 proteins.
Combined test for COVID-19 and influenza A and B detection.
Investors in Binax
Binax has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Abbott Global Point of Care.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Rapid diagnostics products and solutions for point-of-care testing are provided. | 1900 | globalpointofcare.abbott | Waukegan, United States |
Investor details for Binax
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Binax
2 dated milestones of Binax across 19 years, from founding to its latest funding, stage changes and deals.
- Founded Binax is founded.
- Exit Acquired by Abbott.
Competitors of Binax
Binax has 3 listed competitors in our database, 3 of them funded. They include Inflammatix, Karius and Visby Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| inflammatix.com | 2016 | San Francisco, United States | $191.47M | 54 | Provider of diagnostic solutions for systemic infections | |
| kariusdx.com | 2014 | Redwood, United States | $315M | 139 | Developer of a non-invasive pathogen blood test for the detection of infectious diseases | |
| visbymedical.com | 2010 | San Jose, United States | $386.33M | 251 | Portable PCR diagnostics for infectious diseases are developed. |
Detailed competitors of Binax
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Infectious Diseases
3 companies that operate in the same segment as Binax (Infectious Diseases) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 | |
Therapeutics for drug-resistant bacterial infections are developed. | 2013 | Cambridge, Massachusetts, United States | USD 114.7 M | USD 59.62 M | 32 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Binax
Binax was founded in 1986.
Binax is headquartered in Portland, United States. It is registered at Portland, Oregon, United States.
Binax is focused in the development, manufacture, and marketing of a wide range of diagnostic tests for infectious diseases. The company sells a range of lateral flow immunochromatographic assay based tests for Legionella pneumophila, Streptococcus pneumoniae, Strep A, Flu A, Flu B, Ragged stunt virus, NOW Malaria, Hepatitis B, and Filariasis tests. The company was acquired by Inverness Medical Innovations, Inc in Feb, 2005.
Binax's top competitors include Visby Medical, Inflammatix and Karius.
Binax offers BinaxNOW COVID-19 Antigen Self Test and BinaxNOW COVID-19/Flu A&B Combo Self Test.
Binax has 1 investor. Key investors include Abbott Global Point of Care.
Yes. Binax was acquired by Abbott in February 2005.